191 related articles for article (PubMed ID: 15994441)
1. Heparin-binding epidermal growth factor-like growth factor, collateral vessel development, and angiogenesis in skeletal muscle ischemia.
Chalothorn D; Moore SM; Zhang H; Sunnarborg SW; Lee DC; Faber JE
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1884-90. PubMed ID: 15994441
[TBL] [Abstract][Full Text] [Related]
2. Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction.
Borer JG; Park JM; Atala A; Nguyen HT; Adam RM; Retik AB; Freeman MR
Lab Invest; 1999 Nov; 79(11):1335-45. PubMed ID: 10576204
[TBL] [Abstract][Full Text] [Related]
3. Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice.
Stabile E; Burnett MS; Watkins C; Kinnaird T; Bachis A; la Sala A; Miller JM; Shou M; Epstein SE; Fuchs S
Circulation; 2003 Jul; 108(2):205-10. PubMed ID: 12821542
[TBL] [Abstract][Full Text] [Related]
4. The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells and smooth muscle cells.
Kayanoki Y; Higashiyama S; Suzuki K; Asahi M; Kawata S; Matsuzawa Y; Taniguchi N
Biochem Biophys Res Commun; 1999 May; 259(1):50-5. PubMed ID: 10334914
[TBL] [Abstract][Full Text] [Related]
5. Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury.
Pillai SB; Hinman CE; Luquette MH; Nowicki PT; Besner GE
J Surg Res; 1999 Dec; 87(2):225-31. PubMed ID: 10600353
[TBL] [Abstract][Full Text] [Related]
6. Gastrin enhances the angiogenic potential of endothelial cells via modulation of heparin-binding epidermal-like growth factor.
Clarke PA; Dickson JH; Harris JC; Grabowska A; Watson SA
Cancer Res; 2006 Apr; 66(7):3504-12. PubMed ID: 16585174
[TBL] [Abstract][Full Text] [Related]
7. Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries.
Lucchesi PA; Sabri A; Belmadani S; Matrougui K
Circulation; 2004 Dec; 110(23):3587-93. PubMed ID: 15557365
[TBL] [Abstract][Full Text] [Related]
8. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
[TBL] [Abstract][Full Text] [Related]
9. Impact of mouse strain differences in innate hindlimb collateral vasculature.
Helisch A; Wagner S; Khan N; Drinane M; Wolfram S; Heil M; Ziegelhoeffer T; Brandt U; Pearlman JD; Swartz HM; Schaper W
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):520-6. PubMed ID: 16397137
[TBL] [Abstract][Full Text] [Related]
10. Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA.
Provenzano AP; Besner GE; James PF; Harding PA
Growth Factors; 2005 Mar; 23(1):19-31. PubMed ID: 16019424
[TBL] [Abstract][Full Text] [Related]
11. Timing, route, and dose of administration of heparin-binding epidermal growth factor-like growth factor in protection against intestinal ischemia-reperfusion injury.
Martin AE; Luquette MH; Besner GE
J Pediatr Surg; 2005 Nov; 40(11):1741-7. PubMed ID: 16291163
[TBL] [Abstract][Full Text] [Related]
12. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2.
Heil M; Ziegelhoeffer T; Wagner S; Fernández B; Helisch A; Martin S; Tribulova S; Kuziel WA; Bachmann G; Schaper W
Circ Res; 2004 Mar; 94(5):671-7. PubMed ID: 14963007
[TBL] [Abstract][Full Text] [Related]
13. Loss of HB-EGF in smooth muscle or endothelial cell lineages causes heart malformation.
Nanba D; Kinugasa Y; Morimoto C; Koizumi M; Yamamura H; Takahashi K; Takakura N; Mekada E; Hashimoto K; Higashiyama S
Biochem Biophys Res Commun; 2006 Nov; 350(2):315-21. PubMed ID: 17010937
[TBL] [Abstract][Full Text] [Related]
14. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway.
Yang X; Zhu MJ; Sreejayan N; Ren J; Du M
Mol Cells; 2005 Oct; 20(2):263-70. PubMed ID: 16267402
[TBL] [Abstract][Full Text] [Related]
16. The gene for heparin-binding epidermal growth factor-like growth factor is stress-inducible: its role in cerebral ischemia.
Kawahara N; Mishima K; Higashiyama S; Taniguchi N; Tamura A; Kirino T
J Cereb Blood Flow Metab; 1999 Mar; 19(3):307-20. PubMed ID: 10078883
[TBL] [Abstract][Full Text] [Related]
17. Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway.
Roztocil E; Nicholl SM; Galaria II; Davies MG
Surgery; 2005 Aug; 138(2):180-6. PubMed ID: 16153425
[TBL] [Abstract][Full Text] [Related]
18. Temporal patterns of gene expression after acute hindlimb ischemia in mice: insights into the genomic program for collateral vessel development.
Lee CW; Stabile E; Kinnaird T; Shou M; Devaney JM; Epstein SE; Burnett MS
J Am Coll Cardiol; 2004 Feb; 43(3):474-82. PubMed ID: 15013133
[TBL] [Abstract][Full Text] [Related]
19. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor.
Iivanainen E; Nelimarkka L; Elenius V; Heikkinen SM; Junttila TT; Sihombing L; Sundvall M; Maatta JA; Laine VJ; Yla-Herttuala S; Higashiyama S; Alitalo K; Elenius K
FASEB J; 2003 Sep; 17(12):1609-21. PubMed ID: 12958167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
